S2k guideline diagnosis, prevention, and therapy of hand eczema

DC ElementWertSprache
dc.contributor.authorBauer, Andrea
dc.contributor.authorBrans, Richard
dc.contributor.authorBrehler, Randolf
dc.contributor.authorBüttner, Marion
dc.contributor.authorDickel, Heinrich
dc.contributor.authorElsner, Peter
dc.contributor.authorFartasch, Manigé
dc.contributor.authorHerzog, Claudia
dc.contributor.authorJohn, Swen-Malte
dc.contributor.authorKöllner, Arno
dc.contributor.authorMaul, Julia-Tatjana
dc.contributor.authorMerk, Hans
dc.contributor.authorMolin, Sonja
dc.contributor.authorNast, Alexander
dc.contributor.authorNikolakis, Georgios D.
dc.contributor.authorSchliemann, Sybille
dc.contributor.authorSkudlik, Christoph
dc.contributor.authorWeisshaar, Elke
dc.contributor.authorWerfel, Thomas
dc.contributor.authorZidane, Miriam
dc.contributor.authorWorm, Margitta
dc.date.accessioned2024-01-04T10:28:36Z-
dc.date.available2024-01-04T10:28:36Z-
dc.date.issued2023
dc.identifier.issn1610-0379
dc.identifier.urihttp://osnascholar.ub.uni-osnabrueck.de/handle/unios/72873-
dc.descriptionCited by: 1; All Open Access, Hybrid Gold Open Access
dc.description.abstractThe consensus-based guideline “Diagnosis, prevention, and treatment of hand eczema (HE)” provides concrete instructions and recommendations for diagnosis, prevention, and therapy of HE based on an evidence- and consensus-based approach. The guideline was created based on the German guideline “Management von Handekzemen” from 2009 and the current guideline of the European Society of Contact Dermatitis (ESCD) “Guidelines for diagnosis, prevention, and treatment of hand eczema” from 2022. The general goal of the guideline is to provide dermatologists and allergologists in practice and clinics with an accepted, evidence-based decision-making tool for selecting and conducting suitable and sufficient therapy for patients with hand eczema. The guideline is based on two Cochrane reviews of therapeutic and preventive interventions for HE. The remaining chapters were mainly developed and consented based on non-systematic literature research by the expert group. The expert group consisted of members of allergological and occupational dermatological professional associations and working groups, a patient representative, and methodologists. The proposals for recommendations and key statements were consented by using a nominal group process during a consensus conference on September 15, 2022. The structured consensus-building process was professionally moderated. This guideline is valid until February 22, 2028. © 2023 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofJDDG - Journal of the German Society of Dermatology
dc.subjectConsensus
dc.subjectDermatitis, Contact
dc.subjectEczema
dc.subjectHumans
dc.subjectacitretin
dc.subjectalitretinoin
dc.subjectazathioprine
dc.subjectcalcineurin inhibitor
dc.subjectcyclosporine
dc.subjectdupilumab
dc.subjectglucocorticoid
dc.subjectimmunoglobulin E
dc.subjectmethotrexate
dc.subjecttopical agent
dc.subjectArticle
dc.subjectclinical decision making
dc.subjectclinical examination
dc.subjectconsensus
dc.subjectconsensus development
dc.subjectdermatologist
dc.subjectdisease classification
dc.subjectdisease severity
dc.subjectevidence based medicine
dc.subjectexposure
dc.subjecthand eczema
dc.subjecthuman
dc.subjectimmunoglobulin blood level
dc.subjectimmunologist
dc.subjectlocal therapy
dc.subjectmedical history
dc.subjectmedical society
dc.subjectmicrobiological examination
dc.subjectmolecular diagnosis
dc.subjectnomenclature
dc.subjectoccupational eczema
dc.subjectpatch test
dc.subjectphototherapy
dc.subjectphysical examination
dc.subjectphysiotherapy
dc.subjectpractice guideline
dc.subjectprick test
dc.subjectprimary prevention
dc.subjectrisk assessment
dc.subjectrisk factor
dc.subjectskin biopsy
dc.subjectskin protection
dc.subjectsystemic therapy
dc.subjecttopical treatment
dc.subjecttreatment duration
dc.subjectcontact dermatitis
dc.subjecteczema
dc.subjectclinical practice
dc.subjectCochrane Library
dc.subjectevidence based practice
dc.subjectgroup process
dc.subjecthand eczema
dc.subjecttreatment indication
dc.titleS2k guideline diagnosis, prevention, and therapy of hand eczema
dc.typejournal article
dc.identifier.doi10.1111/ddg.15179
dc.identifier.scopus2-s2.0-85160236923
dc.identifier.urlhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85160236923&doi=10.1111%2fddg.15179&partnerID=40&md5=ef3ea148afb51e9bb9f108bf060dd317
dc.description.volume21
dc.description.issue9
dc.description.startpage1054 – 1074
dcterms.isPartOf.abbreviationJDDG J. German Soc. Dermatol.
local.import.remainsaffiliations : Department of Dermatology, University Hospital Carl Gustav Carus, Technical University Dresden, Germany; Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Osnabrück, Germany and Institute for Interdisciplinary Dermatologic Prevention and Rehabilitation (iDerm) at the University of Osnabrück, Osnabrück, Germany; Department of Allergy, Occupational Dermatology and Environmental Medicine, University Hospital Münster, Münster, Germany; Privat practice for dermatology, Dieburg, Germany; Bochum Department of Dermatology, Venereology and Allergology, St. Josef Hospital, University Medical Center, Ruhr University Bochum, Bochum, Germany; Privat practice for dermatology and allergology, SRH Hospital Gera, Germany; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr University Bochum, Bochum, Germany; University Cancer Center, University Hospital Carl Gustav Carus, Technical University Dresden, Germany; Dermatology Group Practice, Duisburg, Germany; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland; of Dermatology and Allergology, Former Chairman of the Department of Dermatology, RWTH University, Aachen, Germany; Division of Dermatology, Department of Medicine, Queen's University, Kingston, Canada; Department of Dermatology, Venereology and Allergology, Division of Evidence-Based Medicine (dEBM), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Departments of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany; Department of Dermatology, University Hospital Jena, Jena, Germany; Occupational Dermatology, Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany; Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany; Department of Dermatology, Venereology and Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
local.import.remainscorrespondence_address : A. Bauer; MPH University Allergy Cener (UAC), Department of Dermatology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Fetscherstraße 74, 01307, Germany; email: andrea.bauer@ukdd.de
local.import.remainspmid : 37700424
local.import.remainspublication_stage : Final
crisitem.author.deptUniversität Osnabrück-
crisitem.author.deptUniversität Osnabrück-
crisitem.author.deptUniversität Osnabrück-
crisitem.author.orcid0000-0002-1245-024X-
crisitem.author.orcid0000-0001-5406-9458-
crisitem.author.netidJoSw269-
Zur Kurzanzeige

Seitenaufrufe

1
Letzte Woche
0
Letzter Monat
0
geprüft am 21.05.2024

Google ScholarTM

Prüfen

Altmetric